相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial
John Chalmers et al.
HYPERTENSION (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Calcium channel blockers and dementia
V. Nimmrich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
β-Adrenergic Blockade in Cardiovascular Disease
William H. Frishman
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone
Shokei Kim-Mitsuyama et al.
KIDNEY INTERNATIONAL (2013)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Stephan D. Fihn et al.
CIRCULATION (2012)
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina
H. L. Elliott et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick et al.
STROKE (2011)
Effect of Valsartan or Olmesartan Addition to Amlodipine on Ankle Edema in Hypertensive Patients
Roberto Fogari et al.
ADVANCES IN THERAPY (2010)
Triple Therapy With Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide in Adult Patients With Hypertension: The TRINITY Multicenter, Randomized, Double-Blind, 12-Week, Parallel-Group Study
Suzanne Oparil et al.
CLINICAL THERAPEUTICS (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial
S. Oparil et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
S. G. Chrysant et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Management of stable coronary artery disease
Matthias E. Pfisterer et al.
LANCET (2010)
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
David S. Wald et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide A Randomized Clinical Trial
David A. Calhoun et al.
HYPERTENSION (2009)
Protective Effects of Efonidipine, a T and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy
Hidehisa Sasaki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
The Use of a Single-Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo-Controlled, Multicenter Study
Joel M. Neutel et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Blood pressure-lowering effects of statins: who benefits?
Leonelo E. Bautista
JOURNAL OF HYPERTENSION (2009)
Molecular Pharmacology of Human Cav3.2 T-Type Ca2+ Channels: Block by Antihypertensives, Antiarrhythmics, and Their Analogs
Edward Perez-Reyes et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The combination of olmesartan medoxomil and Amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
Steven G. Chrysant et al.
CLINICAL THERAPEUTICS (2008)
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis
Jose L. Martin-Ventura et al.
KIDNEY INTERNATIONAL (2008)
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
Kenneth Jamerson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial)
Munekazu Ryuzaki et al.
JOURNAL OF HYPERTENSION (2007)
Amlodipine and stroke prevention
Jean-Luc Balligand et al.
HYPERTENSION (2007)
Fixed-dose combinations improve medication compliance: A meta-analysis
Sripal Bangalore et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers - A quantitative overview
Ji-Guang Wang et al.
HYPERTENSION (2007)
Calcium channel antagonists: Clinical uses-past, present and future
David J. Triggle
BIOCHEMICAL PHARMACOLOGY (2007)
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
Frans H. H. Leenen et al.
HYPERTENSION (2006)
The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells
Suzan Batova et al.
CARDIOVASCULAR RESEARCH (2006)
Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis
T Godfraind
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2005)
Calcium channel blocker inhibits western-type diet-evoked atherosclerosis development in ApoE-deficient mice
J Kyselovic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):: randomised controlled trial
PA Poole-Wilson et al.
LANCET (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF study)
A De Simone et al.
EUROPEAN HEART JOURNAL (2003)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment
K Hayashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Calcium antagonist, lacidipine slows down progression of asymptomatic carotid atherosclerosis -: Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial
A Zanchetti et al.
CIRCULATION (2002)
The prevention of dementia with antihypertensive treatment
F Forette et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Evidence-based evaluation of calcium channel blockers for hypertension - Equality of mortality and cardiovascular risk relative to conventional therapy
LH Opie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats
J Kyselovic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension -: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial
RB Devereux et al.
CIRCULATION (2001)
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: Data from a multicenter, randomized, double-blind, 12-week trial
WJ Elliott et al.
CLINICAL THERAPEUTICS (2001)
Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes
A Simon et al.
CIRCULATION (2001)
Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats
P Krenek et al.
HYPERTENSION (2001)
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
B Pitt et al.
CIRCULATION (2000)
Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies
LH Opie et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2000)
分享论文
